D. Washington and . Author, American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2013.

M. Prince, A. Wimo, M. Guerchet, G. C. Ali, Y. T. Wu et al., World Alzheimer Report, 2015.

U. K. London, Alzheimer's Dis Int, pp.1-92, 2015.

G. Livingston, A. Sommerlad, V. Orgeta, S. G. Costafreda, J. Huntley et al., Dementia prevention, intervention, and care, Lancet, vol.390, pp.2673-734, 2017.

P. Vemuri, T. G. Lesnick, S. A. Przybelski, D. S. Knopman, V. J. Lowe et al., Age, vascular health, and Alzheimer disease biomarkers in an elderly sample, Ann Neurol, vol.82, issue.5, pp.706-724, 2017.

J. Booth, A Short History of Blood Pressure Measurement, J R Soc Med, vol.70, issue.11, pp.793-802, 1977.

H. Lewis and W. , The Evolution of Clinical Sphygmomanometry, Bull N Y Acad Med, vol.17, issue.11, pp.871-81, 1941.

L. Sy and E. Tj, 90th Anniversary of the Development by Nikolai S. Korotkoff of the Auscultatory Method of Measuring Blood Pressure. Circulation, vol.94, pp.116-124, 1996.

W. Osler, An Address ON HIGH BLOOD PRESSURE: ITS ASSOCIATIONS, ADVANTAGES, AND DISADVANTAGES: Delivered at the Glasgow Southern Medical Society, Br Med J, vol.2, pp.1173-1180, 1912.

H. Selye, The general adaptation syndrome and the diseases of adaptation, J Allergy, vol.17, p.231, 1946.

, Kotchen -2011 -Historical Trends and Milestones in Hypertension

C. M. Vargas, D. D. Ingram, and R. F. Gillum, Incidence of Hypertension and Educational Attainment The NHANES I Epidemiologic Followup Study, Am J Epidemiol, vol.152, issue.3, pp.272-280, 2000.

S. S. Mahmood, D. Levy, R. S. Vasan, and T. J. Wang, The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective, Lancet, vol.383, issue.9921, pp.999-1008, 2014.

T. R. Dawber, F. E. Moore, and G. V. Mann, Coronary heart disease in the Framingham study, Am J Public Health Nations Health, vol.47, issue.4, pp.4-24, 1957.

J. Stamler, R. Stamler, and J. D. Neaton, Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data, Arch Intern Med, vol.153, issue.5, pp.598-615, 1993.

. Has.-fiche and . Mémo, Prise en charge de l'hypertension artérielle de l'adulte, 2016.

, Évaluation des technologies de santé. Analyse Médico-économique. Évaluation par classe des médicaments antihypertenseurs, pp.1-250, 2013.

A. Perrine, C. L. , J. B. Olié, V. L'hypertension-artérielle-en, and F. , prévalence, traitement et contrôle en 2015 et évolutions depuis 2006, vol.10, pp.170-179, 2018.

K. T. Mills, J. D. Bundy, T. N. Kelly, J. E. Reed, P. M. Kearney et al., Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries, Circulation, vol.134, issue.6, pp.441-50, 2009.

A. R. Borenstein and J. A. Mortimer, Chapter 1 -The "First" Case, pp.3-5, 2016.

M. B. First, M. Crocq, and R. M. Moraru, , 2016.

J. C. Morris, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, vol.43, issue.11, pp.2412-2416, 1993.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state": A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-98, 1975.

A. R. Borenstein and J. A. Mortimer, Chapter 2 -Clinical Appearance, Progression, and Classification, pp.7-23, 2016.

D. J. Selkoe and J. Hardy, The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol Med, vol.8, issue.6, pp.595-608, 2016.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, issue.4, pp.239-59, 1991.

Y. Shi and J. M. Wardlaw, Update on cerebral small vessel disease: A dynamic whole-brain disease, Stroke and Vascular Neurology, vol.1, 2016.

J. M. Wardlaw, C. Smith, and M. Dichgans, Small vessel disease: mechanisms and clinical implications, Lancet Neurol, vol.18, issue.7, pp.684-96, 2019.

J. Alber, S. Alladi, H. J. Bae, D. A. Barton, L. A. Beckett et al., White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's Dement, Transl Res Clin Interv, vol.5, pp.107-124, 2019.

S. Debette and H. S. Markus, The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis, BMJ, vol.341, issue.7767, p.288, 2010.

D. Bos, F. J. Wolters, S. Darweesh, M. W. Vernooij, F. De-wolf et al., Cerebral small vessel disease and the risk of dementia: A systematic review and meta-analysis of population-based evidence, vol.14, pp.1482-92, 2018.

K. Blennow, N. Mattsson, M. Schöll, O. Hansson, and H. Zetterberg, Amyloid biomarkers in Alzheimer's disease, Trends Pharmacol Sci, vol.36, issue.5, pp.297-309, 2015.

K. Buerger, M. Ewers, T. Pirttilä, R. Zinkowski, I. Alafuzoff et al., CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease, Brain, vol.129, issue.11, pp.3035-3076, 2006.

J. P. Kesslak, O. Nalcioglu, and C. W. Cotman, Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease, Neurology, 1991.

B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco et al., The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals, Cereb Cortex, vol.19, issue.3, pp.497-510, 2009.

P. J. Toussaint, V. Perlbarg, P. Bellec, S. Desarnaud, L. Lacomblez et al., Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses, Neuroimage, vol.63, issue.2, pp.936-982, 2012.

X. Song, A. Mitnitski, and K. Rockwood, Age-related deficit accumulation and the risk of latelife dementia. Alzheimer's Res Ther, vol.6, pp.5-8, 2014.

M. J. Valenzuela, Brain reserve and the prevention of dementia, Curr Opin Psychiatry, vol.21, issue.3, pp.296-302, 2008.

C. R. Jack, D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner et al., Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-223, 2013.

M. R. Azarpazhooh, A. Avan, L. E. Cipriano, D. G. Munoz, L. A. Sposato et al.,

, Concomitant vascular and neurodegenerative pathologies double the risk of dementia

&. Alzheimer and . Dement, , vol.14, pp.148-56, 2018.

J. A. Schneider, Z. Arvanitakis, W. Bang, and D. A. Bennett, Mixed brain pathologies account for most dementia cases in community-dwelling older persons, Neurology, vol.69, pp.2197-204, 2007.

L. Carcaillon-bentata, C. Quintin, E. Moutengou, M. Boussac-zarebska, F. Moisan et al.,

. Peut-on, Alzheimer et autres démences à partir des bases de données médico-administratives ? Comparaison aux données de cohortes populationnelles, Bull Epidémiol Hebd, pp.459-67, 2016.

E. Schrijvers, B. Verhaaren, P. J. Koudstaal, A. Hofman, M. A. Ikram et al., Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study, Neurology, vol.78, pp.1456-63, 2012.

C. Qiu, V. Strauss, E. Bäckman, L. Winblad, B. Fratiglioni et al., Twenty-year changes in dementia occurrence suggest decreasing incidence in central, Neurology, vol.80, issue.20, pp.1888-94, 2013.

F. E. Matthews, B. Stephan, L. Robinson, C. Jagger, L. E. Barnes et al., A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II, Nat Commun, vol.7, p.11398, 2016.

A. Lobo, P. Saz, M. G. Dia, J. L. De-la-camara, C. Ventura et al., Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project, Acta Psychiatr Scand, vol.116, issue.4, pp.299-307, 2007.

C. Helmer, L. Grasset, K. Pérès, and J. Dartigues, Évolution temporelle des démences : état des lieux en France et à l'international, Bull Epidémiol Hebd, pp.467-73, 2016.

W. B. White, F. Jalil, D. B. Wakefield, R. F. Kaplan, R. W. Bohannon et al., Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension, Am Heart J, vol.205, pp.21-30, 2018.

C. Iadecola, K. Yaffe, J. Biller, L. C. Bratzke, F. M. Faraci et al., Impact of Hypertension on Cognitive Function, vol.68

S. F. Sorrells, M. F. Paredes, A. Cebrian-silla, K. Sandoval, D. Qi et al., Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults, Nature, vol.555, issue.7696, pp.377-81, 2018.

F. Forette, M. Seux, J. A. Staessen, L. Thijs, M. Babarskiene et al., The Prevention of Dementia With Antihypertensive Treatment: New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study, Arch Intern Med, vol.162, issue.18, pp.2046-52, 2002.

J. Ding, K. L. Davis-plourde, S. Sedaghat, P. J. Tully, W. Wang et al., Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies, Lancet Neurol, vol.19, issue.1, 2019.

J. D. Williamson, N. M. Pajewski, A. P. Auchus, R. N. Bryan, G. Chelune et al., Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial, JAMA -J Am Med Assoc, vol.321, issue.6, pp.553-61, 2019.

K. Kisler, A. R. Nelson, A. Montagne, and B. V. Zlokovic, Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease, Nat Rev Neurosci, vol.18, issue.7, pp.419-453, 2017.

C. Dufouil, B. Dubois, B. Vellas, F. Pasquier, F. Blanc et al., Cognitive and imaging markers in non-demented subjects attending a memory clinic: Study design and baseline findings of the MEMENTO cohort, vol.9, pp.1-13, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01580853

M. Van-der-linden, F. Coyette, J. Poitrenaud, M. Kalafat, F. Calicis et al., L'épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16), 2004.

C. G. Schwarz, J. L. Gunter, H. J. Wiste, S. A. Przybelski, S. D. Weigand et al., A largescale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity, NeuroImage Clin, vol.11, pp.802-814, 2016.

P. Lewczuk, N. Lelental, P. Spitzer, J. M. Maler, and J. Kornhuber, Amyloid-? 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays, J Alzheimer's Dis, vol.43, pp.183-91, 2015.

W. S. Aronow, J. L. Fleg, C. J. Pepine, N. T. Artinian, G. Bakris et al., , 2011.

, Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American. J Am Coll Cardiol, vol.57, issue.20, pp.2037-114, 2011.

D. L. Schminkey, T. Von-oertzen, and L. Bullock, Handling Missing Data With Multilevel Structural Equation Modeling and Full Information Maximum Likelihood Techniques

, Res Nurs Health, vol.39, issue.4, pp.286-97, 2016.

B. Rizvi, A. Narkhede, B. S. Last, M. Budge, G. Tosto et al., The effect of white matter hyperintensities on cognition is mediated by cortical atrophy, Neurobiol Aging, vol.64, pp.25-32, 2018.

C. R. Jack, D. A. Bennett, K. Blennow, M. C. Carrillo, B. Dunn et al., Toward a biological definition of Alzheimer's disease. Alzheimer's Dement, vol.14, pp.535-62, 2018.

M. D. Sweeney, A. Montagne, A. P. Sagare, D. A. Nation, L. S. Schneider et al., Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimer's Dement, vol.15, pp.158-67, 2019.

J. Graff-radford, H. Botha, A. A. Rabinstein, J. L. Gunter, S. A. Przybelski et al., Cerebral microbleeds: Prevalence and relationship to amyloid burden, Neurology, vol.92, issue.3, pp.253-62, 2019.

A. Soldan, C. Pettigrew, Y. Zhu, M. Wang, A. Moghekar et al., White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease, Neurology, vol.94, issue.9, pp.950-60, 2020.